Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RACELINES: Empagliflozin and Linagliptin in T2DM
NCT03433248Phase 4Unknown
- Start
- Nov 2017
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin, linagliptin in type 2 diabetes mellitus (T2DM). Status: unknown.
02
Drugs
empagliflozinlinagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03433248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03433248.